Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy.
about
Morbidity and mortality after esophagectomy for esophageal carcinoma: a risk analysisThree-field lymph node dissection in treating the esophageal cancerThree-field vs two-field lymph node dissection for esophageal cancer: a meta-analysisSystematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancerEvaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistryThe prognostic effect of perineural invasion in esophageal squamous cell carcinomaTwo-field dissection is enough for esophageal cancer.Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma.Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysisEvaluation of prognosis of squamous cell carcinoma of the oesophagus by endoscopic ultrasonographyThe Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.Quality of life after three kinds of esophagectomy for cancer.A novel method for lymphadenectomy along the left laryngeal recurrent nerve during thoracoscopic esophagectomy for esophageal carcinoma.The dynamic of nasogastric decompression after esophagectomy and its predictive value of postoperative complications.Surgical treatment for esophageal cancer. Current issues.Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagusComparison of robot-assisted esophagectomy and thoracoscopic esophagectomy in esophageal squamous cell carcinoma.Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma.Lymph node dissection for esophageal cancer.Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution.Treatment options for esophageal squamous cell carcinoma.Current status and future perspectives on minimally invasive esophagectomy.History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery.Evaluation of a robot-assisted video-assisted thoracoscopic surgery programme.Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review.Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes.Esophageal Cancer: Current Options for Therapeutic Management.Lymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patients.Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care.Extended lymphadenectomy in esophageal cancer is crucial.A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409.Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression.Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy.Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.Outcomes of thoracoscopic esophagectomy in prone position with laparoscopic gastric mobilization for esophageal cancer.Three-field lymph node dissection in esophageal cancer surgery.Risk Factors and Clinical Outcomes of Recurrent Laryngeal Nerve Paralysis After Esophagectomy for Thoracic Esophageal Carcinoma.
P2860
Q24815272-31BC2423-70CB-46E0-B8A7-DE5BEA399BC5Q28077519-4CCCBFB8-A738-4558-9032-806F4E6D21E5Q28087347-AFDC6E84-2FA7-4E0E-A5EF-51017D1D46C3Q30252079-5F2235A0-A4C4-426F-B587-3902AC537420Q33235427-216E128B-7294-4F3C-8DD4-7540D60849FCQ33398141-B072DD81-C107-4F71-93D0-93D88599F709Q33593057-545310FF-08A2-4BC1-A77D-F3313BA185B1Q34366123-2830D64C-4BC2-4F0B-BB77-4B53F5523B62Q34484367-AE41108E-53BD-4B0D-9C96-30450BAD117AQ35156961-2F4DB007-687C-4449-847D-750D7E671B89Q35158530-EF3FBD38-08C2-4D06-B2A7-57E884E67A30Q35360449-5C342AE6-F1FE-498D-A01C-0347A772D86CQ36194108-44CBFEBF-D3EB-47A6-B7BE-4C80196386D8Q36200617-444ABDBA-1277-465D-8B65-1B139113FC1EQ36285826-3A422D5F-3879-4AEC-95C8-7C935603378FQ36540340-320C9388-75AA-45EF-B81C-3BDC8E258470Q36587331-CA6C000D-ED96-4958-9F89-F6EDD1DA4DC3Q36796757-E67F5835-7902-466B-8F53-C13ACF2F255AQ37098252-9B99F27A-A62D-4882-BD6E-56EF9A720305Q37411091-461E3FD9-7CB6-477C-91E8-B03DA49D50CEQ37559802-C568272C-B4E3-449E-B73D-4C95A0803EC8Q38093060-46BC312C-DEF4-40CC-8A00-BCEE01271005Q38103633-06E988EA-5595-4C93-B321-26A825115E04Q38107007-AC298901-6E78-4579-AF9D-A478CD8BAC52Q38134075-D17CD03A-367E-4A1C-9994-13D92082F741Q38187353-73208827-3CAE-408C-8742-5943CDB81454Q38372661-0D9A31D8-7040-417E-BE46-DA877F0D24CDQ38414477-3A06E70A-BDB7-4806-B83F-7C1ED7614F7EQ38621206-8D501F6F-715B-49EF-B2E4-5034F3697425Q38671121-82FB1E12-126D-4C05-94D6-2475D5483663Q38681123-765C5CAC-EC64-4160-BF96-3A0E62BD73D1Q38977468-5992195D-1B87-4DDF-9AA7-AA4623284F3FQ39428779-D5E41C97-256C-48E0-94CA-83448A8821CBQ40144003-FDAA63A0-A254-428E-A001-3E5B5BABD90BQ40229704-F6A2BC74-5B6A-42CB-BE11-9589979483BAQ40351556-6AEB642F-18AD-46F4-8698-9688A08BDB06Q40579133-4758C841-C8B2-439C-AF3D-48E2086FE6FDQ40735603-CE3925E8-DB48-49DC-A669-9D82F7A6637DQ41202637-45FC770B-3942-4930-970D-3B6381C46226Q41225314-9A326A52-B322-4F35-9D57-77BA077EA597
P2860
Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@en
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@nl
type
label
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@en
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@nl
prefLabel
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@en
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@nl
P2093
P1433
P1476
Mortality and morbidity rates, ...... ith two-field lymphadenectomy.
@en
P2093
Kakegawa T
Yamasaki K
P304
P356
10.1097/00000658-199511000-00008
P407
P577
1995-11-01T00:00:00Z